Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Original Research
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer
Tal Flieswassera Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium;b Department of Pathology, Antwerp University Hospital, Edegem, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0001-6348-3204View further author information
https://orcid.org/0000-0001-6348-3204View further author information, , Laurie Freire Boullosaa Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgiumhttps://orcid.org/0000-0001-6788-6211View further author information
https://orcid.org/0000-0001-6788-6211View further author information, , , , , Jonas Van Audenaerdea Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgiumhttps://orcid.org/0000-0002-5619-1913View further author information
https://orcid.org/0000-0002-5619-1913View further author information, Filip Lardona Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgiumhttps://orcid.org/0000-0001-7174-4144View further author information
https://orcid.org/0000-0001-7174-4144View further author information, Evelien Smitsa Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium;c Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgiumhttps://orcid.org/0000-0001-9255-3435View further author information
https://orcid.org/0000-0001-9255-3435View further author information, Patrick Pauwelsa Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium;b Department of Pathology, Antwerp University Hospital, Edegem, Belgiumhttps://orcid.org/0000-0002-8553-1921View further author information
https://orcid.org/0000-0002-8553-1921View further author information & Julie Jacobsa Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium;d Argenx BV, Zwijnaarde, Belgiumhttps://orcid.org/0000-0003-2873-3364View further author information
https://orcid.org/0000-0003-2873-3364View further author information show all